Cambrex Appoints Steven M. Klosk as President and CEO

In the office.
And on the beach

The web magazine for top managers - who's promoted, who came, who left? And what to do when you're not in the office.

May 18, 2008, East Rutherford, N.J., USA - Cambrex, a life sciences company, announced the Board of Directors appointed Steven M. Klosk, President and Chief Executive Officer and a member of the Cambrex Corporation Board of Directors.

Mr. Klosk holds a Bachelor of Science degree from Cornell University and a J. D. degree from New York Law School. Mr. Klosk joined Cambrex in October 1992 as Vice President-Administration. Mr. Klosk was appointed Executive Vice President, Administration in October 1996, and was promoted to the position of Executive Vice President and Chief Operating Officer for Cambrex Pharma and BioPharmaceutical Business Unit in October 2003. In January 2005 Mr. Klosk assumed direct responsibility for the BioPharmaceutical Business Unit as Chief Operating Officer. In January 2007 he was appointed Executive Vice President and Chief Operating Officer for the Corporation.

James A. Mack, President and Chief Executive Officer since 1995 and Chairman since 1999, has announced he will step down but he will remain a Board member and advisor until his retirement on June 30, 2008. The Company will separate the positions of Board Chairman and CEO and John R. Miller, currently lead director, will assume the position of Non-Executive Chairman of the Board.

Post to: